RLX Technology Inc. research snapshot
RLX AI stock analysis currently reads RLX Technology Inc. as a cash-rich Chinese e-vapor company undergoing a fundamental transition from China-centric to global operations. At the July 13, 2026 data cutoff, RLX traded near $1.885, market capitalization was about $2.32 billion using verified shares of 1.23 billion, and fiscal 2025 GAAP net income was RMB 934.4 million ($133.6 million). The company holds approximately $2.1 billion in total liquid assets, meaning the operating business carries a low enterprise value. This page uses scenario analysis, not a certain stock price prediction, and it is an informational tool rather than investment advice.
Current price
$1.885
Market cap
$2.32 billion
AI score
55 / 100
Rating
Cash-rich Chinese e-vapor company navigating international expansion and regulatory uncertainty
Trend status
Recovery trend from lows but well below 2021 IPO price
Data cutoff (updated weekly)
July 13, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | RLX Technology sells branded e-vapor products (RELX) in China and internationally. Q1 2026 net revenues grew 96.2% YoY to RMB 1.59 billion, driven by international expansion and the May 2025 European acquisition. | Medium |
| Moat | The moat is moderate and improving internationally through brand, distribution partnerships, regulatory compliance capability, and manufacturing scale. Switching costs are low in e-vapor and regulatory barriers can work both for and against incumbent players. | Low-medium |
| Management | Founder and CEO Kate Wang and CFO Chao Lu have navigated severe Chinese regulatory headwinds since 2021, pivoted the business to international markets, and maintained a fortress balance sheet with active capital returns via buybacks and dividends. | Medium |
| Financial trend | FY2025 net revenues grew 44.0% to RMB 3.96 billion, GAAP net income grew 65.6% to RMB 934.4 million, and gross margin improved to 29.9% from 26.4%. Q1 2026 continued the momentum with 96.2% revenue growth. | High |
| Valuation | At $1.885 and $0.11 TTM EPS, the verified trailing P/E is 17.14x. However, the stock trades near cash value per share (~$1.71), implying the operating business is valued at a very low multiple of earnings. | High for math, low for regulatory visibility |
| Technical trend | RLX has recovered from its 52-week low near $1.815 but remains far below the $2.84 52-week high and dramatically below the $12 IPO price. The stock shows a tentative uptrend on international expansion news. | Low-medium |
| Risk level | Risk is high. Chinese e-vapor regulation, potential US FDA enforcement, competitive pressure in Europe and Asia, foreign ownership rules for Chinese ADRs, and geopolitical tension between the US and China all create material downside scenarios. | Medium-high |
| AI confidence | Medium-high confidence for reported financials, market-cap math, cash position, and valuation math. Lower confidence for regulatory trajectory, international growth durability, and next-phase multiple support. | Medium-high data confidence |
| Investment certainty | Medium-low certainty. The cash position provides a floor, but the operating business faces structural regulatory and competitive risks that are hard to model with confidence. | Low-medium |
RLX AI stock forecast
The RLX AI stock forecast uses scenario ranges around the $1.885 quote. The bullish case requires sustained international revenue momentum, gross margin expansion, regulatory stability, and market recognition of the asset-light enterprise value. The base case assumes continued international growth with China stabilization. The bearish case assumes regulatory setbacks or international competition pressure margins.
$3.50 to $6.00
More likely if international revenue continues growing at 40%+ annually, gross margin expands above 32%, Chinese domestic market stabilizes or recovers, the company continues buybacks, and the market re-rates the stock closer to 20x+ earnings on improving EPS trajectory.
$2.00 to $3.00
More likely if international growth moderates to 20-30%, China market remains flat to slightly recovering, gross margin holds near 30%, and the stock trades in a 15-18x P/E range on steady EPS growth.
$1.10 to $1.80
More likely if Chinese regulatory pressure intensifies, international expansion faces competitive or regulatory headwinds, US-China tensions affect ADR access, or gross margin contracts from aggressive pricing.
RLX AI technical analysis
RLX AI technical analysis starts from the $1.885 quote near the July 13, 2026 cutoff, the $1.815 to $2.84 52-week range, and available moving-average data. Because this static page does not fetch request-time chart data, live price, volume, RSI, and moving averages should be confirmed before trading.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $1.885 | Quote used for this page near the July 13, 2026 data cutoff. |
| Near support | $1.815 to $1.85 | The 52-week low of $1.815 provides the nearest identifiable support level. A break below would test uncharted lows. |
| Deeper support | $1.50 to $1.70 | If the 52-week low breaks, psychological round numbers and pre-2025 trading ranges may provide the next support zone. |
| Near resistance | $2.00 to $2.15 | The $2.00 psychological level and recent trading range highs act as initial resistance. |
| Key resistance | $2.50 to $2.84 | The upper bound is the 52-week high. A decisive break above $2.50 with volume would signal a stronger trend change. |
| Volume | About 692,000 daily (avg 2.49 million) | Current daily volume is below the average, suggesting consolidation. A volume spike above average on a breakout would add confidence. |
| Volatility | Moderate, beta 1.14 | Beta of 1.14 indicates slightly higher volatility than the broad market, typical for a small-cap Chinese ADR. |
| Invalidation | Close below $1.815 | A decisive close below the 52-week low would invalidate the recovery setup and suggest further downside risk. |
RLX AI trading strategy
The RLX AI trading strategy is a rules-based framework for a Chinese ADR e-vapor company in transition. It is not personalized advice. Any setup should be paired with position sizing, stop levels, updated filings, and live chart confirmation.
Wait for RLX to hold above the $1.815 support and reclaim the $2.00 to $2.15 resistance area with improving volume. Monitor international revenue growth and regulatory news from China and Europe as fundamental confirmation.
A failed breakout above resistance or a close below $1.815 should invalidate the setup. Position size should reflect the high regulatory uncertainty.
If RLX trades closer to or below cash value per share (~$1.71), the downside is partially protected by the balance sheet. Compare the enterprise value multiple with international e-vapor peers and monitor cash burn or accumulation trends.
Do not treat cash value as a guaranteed floor. Chinese ADR structural risks, including potential delisting or capital controls, can erode the cash value premium. Limit position size accordingly.
Track international revenue share, gross margin trajectory, quarterly cash flow trends, Chinese regulatory announcements, European market expansion, competitive landscape (Smoore, British American Tobacco, Juul), and US-China ADR policy.
Reduce confidence if international revenue growth decelerates for two consecutive quarters, gross margin declines, or regulatory headwinds in key markets intensify.
Investment research summary
Customers buy RLX e-vapor products as an alternative to traditional cigarettes. The company generates revenue from device sales and consumable pods/cartridges, with an increasing share from international markets (72.3% in Q1 2026).
RLX has a moderate and growing moat through its RELX brand recognition, regulatory compliance infrastructure, manufacturing scale at the Nexus hub, and distribution partnerships in Europe and Asia. However, switching costs are low in vaping and competition includes well-funded global tobacco companies.
The thesis can fail if Chinese regulators reimpose severe restrictions on e-vapor, if US-China tensions lead to ADR delisting, if international expansion costs outpace revenue, if global competitors outspend RLX on marketing and distribution, or if public health concerns drive blanket vaping bans in key markets.
CEO Kate Wang co-founded the company in 2018 and has led the strategic pivot from China to global markets after the 2021-2022 regulatory crackdown. Management has maintained a strong balance sheet, returned over $500 million to shareholders via buybacks and dividends, and executed a European acquisition in May 2025.
The global e-vapor market is growing as harm-reduction products gain acceptance, traditional smoking declines, and regulatory frameworks mature. China remains a large potential market, while Europe and developing Asia offer near-term growth. However, the industry faces constant regulatory, health, and public perception risks.
A verified 17.14x trailing P/E and ~$2.32B market cap with ~$2.1B in total liquid assets mean the enterprise is valued at a very low multiple. The current price offers a margin of safety through cash holdings, but the operating business carries regulatory and execution risk that make the cash-adjusted valuation less certain for Chinese ADRs.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| RLX price | $1.885 near the July 13, 2026 data cutoff | Yahoo Finance RLX quote | July 13, 2026 |
| Market capitalization | $2.32 billion, verified as $1.885 x 1,232,448,894 shares (deviation 0.83%) | financial_rigor.py market cap verification | July 13, 2026 |
| Share count | 1,232,448,894 basic ADS/shares as of Q1 2026 | RLX Q1 2026 earnings release | July 13, 2026 |
| FY2025 net revenues | RMB 3,958.9 million ($566.1 million) | RLX FY2025 earnings release | July 13, 2026 |
| FY2025 GAAP net income | RMB 934.4 million ($133.6 million) | RLX FY2025 earnings release | July 13, 2026 |
| Q1 2026 net revenues | RMB 1,585.8 million ($229.9 million), up 96.2% YoY | RLX Q1 2026 earnings release | July 13, 2026 |
| Q1 2026 GAAP net income | RMB 294.2 million ($42.6 million), up 32.1% YoY | RLX Q1 2026 earnings release | July 13, 2026 |
| Total liquid assets | RMB 14,529.7 million ($2,106.4 million) as of March 31, 2026 | RLX Q1 2026 balance sheet | July 13, 2026 |
| International revenue share | 72.3% of Q1 2026 net revenues | RLX Q1 2026 earnings release | July 13, 2026 |
| Valuation math | 17.14x P/E, 1.00x P/B, 1.35x EV/Revenue, 5.43% dividend yield | financial_rigor.py and Yahoo Finance verification | July 13, 2026 |
| Cumulative shareholder returns | $330 million in buybacks and ~$171 million in dividends as of March 2026 | RLX FY2025 earnings release | July 13, 2026 |
| Technical range | 52-week range $1.815 to $2.84 | Yahoo Finance RLX statistics | July 13, 2026 |
This RLX AI stock analysis page is an informational research tool only. It is not investment advice, a recommendation, or a promise of future performance. Forecast ranges are scenarios based on available data as of July 13, 2026 and can be wrong if fundamentals, price action, filings, regulatory environment, or market conditions change.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
